BBI-3000

N/A

Report date: 2025/02/07 11:48:32
NME

Base Information

Drug NameBBI-3000
Drug Alias NameBBI-3000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid X receptor agonists
TargetsRetinoid X receptor
Therapy Area/IndicationsLymphoma, T-Cell, Cutaneous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFresh Tracks Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerz PharmaFresh Tracks Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, T-Cell, Cutaneous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A